Two strategies to interrogate the insulin growth factor @ receptor ( IGF-@R ) pathway were investigated : vertical inhibition with dalotuzumab and MK-@ or ridaforolimus to potentiate PI@K pathway targeting and horizontal cross-talk inhibition with dalotuzumab and MK-@ to exert effects against cellular proliferation , angiogenesis , and stem cell propagation .